Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AbbVie
(NY:
ABBV
)
166.41
+1.75 (+1.06%)
Official Closing Price
Updated: 6:30 PM EDT, Apr 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,532,377
Open
165.02
Bid (Size)
163.25 (1)
Ask (Size)
166.35 (1)
Prev. Close
164.66
Today's Range
163.25 - 166.60
52wk Range
130.96 - 182.89
Shares Outstanding
N/A
Dividend Yield
3.56%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?
Today 14:30 EDT
Small-cap stocks have been the market laggards but these standouts showed how to beat even top-tier tech names at their own game.
Via
InvestorPlace
The Bad News Heading Into AbbVie's First-Quarter Earnings Report
Today 12:43 EDT
AbbVie is working against numerous biosimilar versions of Humira. But one has "stepped up dramatically."
Via
Investor's Business Daily
Performance
YTD
+4.12%
+4.12%
1 Month
-7.38%
-7.38%
3 Month
+1.90%
+1.90%
6 Month
+14.36%
+14.36%
1 Year
+3.23%
+3.23%
More News
Read More
Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson's Disease Study
April 18, 2024
Via
Benzinga
Is Your Botox Real Or Fake? Counterfeit Boxes Circulate For Widely Used Antiwrinkle Treatment, CDC And FDA Investigate Harmful Reactions
April 17, 2024
Via
Benzinga
Exposures
Product Safety
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today
April 17, 2024
Via
Benzinga
AbbVie's Options Frenzy: What You Need to Know
April 15, 2024
Via
Benzinga
Is AbbVie a Millionaire Maker?
April 14, 2024
Via
The Motley Fool
Smart Money Is Betting Big In ABBV Options
April 12, 2024
Via
Benzinga
AbbVie Unusual Options Activity For April 05
April 05, 2024
Via
Benzinga
Powell And The Great Indecision
April 16, 2024
Via
Talk Markets
Topics
Economy
Exposures
Economy
Interest Rates
Steady Income, Steady Growth: 7 Blue-Chip Dividend Stocks to Buy Now
April 16, 2024
Via
InvestorPlace
Avalo Therapeutics' Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades
April 16, 2024
Via
Benzinga
Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug
April 15, 2024
Via
Investor's Business Daily
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors
April 12, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
Smart Money Is Betting Big In ABBV Options
April 04, 2024
Via
Benzinga
What's Going On AbbVie Stock On Friday?
April 12, 2024
Via
Benzinga
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors
April 12, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024
April 11, 2024
Via
InvestorPlace
The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today
April 11, 2024
Via
InvestorPlace
Blindness-Focused LENZ Therapeutics' Investigational Eye Drop Ready To Revolutionize Presbyopia Landscape, Analyst Says
April 10, 2024
Via
Benzinga
The Law Offices of Frank R. Cruz Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors
April 10, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade
April 09, 2024
Via
The Motley Fool
3 No-Brainer Dividend Stocks to Buy in April
April 06, 2024
Via
The Motley Fool
Passive Income Perfection: 7 Dividend Stocks to Generate $50,000 Per Year
April 04, 2024
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
April 03, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.